PortfoliosLab logo

Amylyx Pharmaceuticals, Inc. (AMLX)

Equity · Currency in USD · Last updated Aug 11, 2022

Company Info

ISINUS03237H1014
CUSIP03237H101
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$26.51
EMA (50)$20.61
Average Volume$1.13M
Market Capitalization$1.55B

AMLXShare Price Chart


Chart placeholderClick Calculate to get results

AMLXPerformance

The chart shows the growth of $10,000 invested in Amylyx Pharmaceuticals, Inc. in Jan 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $13,953 for a total return of roughly 39.53%. All prices are adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%40.00%60.00%MarchAprilMayJuneJulyAugust
31.43%
-4.35%
AMLX (Amylyx Pharmaceuticals, Inc.)
Benchmark (^GSPC)

AMLXReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M19.36%7.97%
6M35.19%-6.88%
YTD39.53%-10.35%
1Y39.53%-10.35%
5YN/AN/A
10YN/AN/A

AMLXMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202222.00%41.93%-60.94%-29.96%-1.22%116.65%40.13%-1.78%

AMLXSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The chart below displays rolling 12-month Sharpe Ratio.


Chart placeholderNot enough data

AMLXDividend History


Amylyx Pharmaceuticals, Inc. doesn't pay dividends

AMLXDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%FebruaryMarchAprilMayJuneJulyAugust
-19.42%
-10.92%
AMLX (Amylyx Pharmaceuticals, Inc.)
Benchmark (^GSPC)

AMLXWorst Drawdowns

The table below shows the maximum drawdowns of the Amylyx Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Amylyx Pharmaceuticals, Inc. is 79.18%, recorded on May 11, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-79.18%Mar 1, 202251May 11, 2022
-17.59%Feb 2, 20228Feb 11, 20225Feb 18, 202213
-12.97%Jan 20, 20222Jan 21, 20226Jan 31, 20228
-12%Jan 7, 20222Jan 10, 20221Jan 11, 20223
-7.9%Jan 14, 20222Jan 18, 20221Jan 19, 20223
-3.44%Feb 23, 20221Feb 23, 20221Feb 24, 20222

AMLXVolatility Chart

Current Amylyx Pharmaceuticals, Inc. volatility is 53.57%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%250.00%MarchAprilMayJuneJulyAugust
53.57%
16.23%
AMLX (Amylyx Pharmaceuticals, Inc.)
Benchmark (^GSPC)